XML 33 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of stock option activity
The following is a summary of service vesting based related stock option activity for the three month period ended March 31, 2017, and the status of stock options outstanding at March 31, 2017:
 
 
 
Three Month Period Ended
 
 
 
March 31, 2017
 
 
 
 
 
 
Wtd. Avg.
 
 
 
 
 
 
Exercise
 
 
 
Options
 
Price
 
Outstanding at beginning of year
 
 
2,513,861
 
$
1.78
 
Granted
 
 
110,000
 
$
1.79
 
Exercised
 
 
(107,142)
 
$
1.12
 
Forfeited
 
 
(47,783)
 
$
3.59
 
Expired
 
 
(81,352)
 
$
1.27
 
Outstanding at March 31, 2017
 
 
2,387,584
 
$
1.79
 
 
 
 
 
 
 
 
 
Stock options exercisable at March 31, 2017
 
 
1,257,183
 
$
1.69
 
Weighted average assumptions of share based payment
The fair value of share-based payments made with stock options to employees and non-employee directors was estimated on the measurement date using the Black-Scholes model using the following weighted average assumptions.
 
 
Three Month Period Ended
 
 
March 31,
 
 
2017
 
2016
 
Risk free interest rate
 
 
2.07
%
 
 
1.65
%
Dividend yield
 
 
0.0
%
 
 
0.0
%
Expected term (in years)
 
 
5.18
 
 
 
7.00
 
Volatility
 
 
75
%
 
 
75
%
Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following is a summary of restricted stock activity for the three month period ended March 31, 2017, and the status of unvested restricted stock outstanding at March 31, 2017:
 
 
 
Three Month Period Ended
 
 
 
March 31, 2017
 
 
 
Number of
 
 
 
 
 
Restricted
 
Grant-Date
 
 
 
Shares
 
Fair Value
 
Unvested outstanding at beginning of year
 
 
98,439
 
$
1.90
 
Granted
 
 
207,350
 
$
1.76
 
Vested
 
 
(23,439)
 
$
1.90
 
Outstanding at March 31, 2017
 
 
282,350
 
$
1.80
 
Stock compensation expense
We recorded total stock compensation expense for the three month periods ended March 31, 2017 and 2016, as follows:
 
 
 
Three Month Period Ended
 
 
 
March 31,
 
 
 
2017
 
2016
 
Research and development costs
 
$
59,265
 
$
37,469
 
Sales and marketing costs
 
 
59,619
 
 
63,499
 
General and administrative costs
 
 
168,198
 
 
77,510
 
Cost of product sales
 
 
42,813
 
 
(31,951)
 
Total
 
$
329,895
 
$
146,527